FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Nils Schoof

Research Profile

Genes & Molecular Sequences

Single Nucleotide Polymorphism

Chemicals & Drugs

Physiology

Genotype

Concepts & Ideas

Procedures

Case Control Studies

Living Beings

Young Adult

Disorders

Anatomy

Jurkat Cells

Co-author Network

Publications

TOP 3
Nils Schoof; Lorenz Trümper; Frederike von Bonin; Thomas Zander; Volker Diehl; Andreas Engert; Jeremy Franklin; Robert Fürst; Martin Hafner; Frédéric Peyrade; Daniel Re
Interleukin-10 gene polymorphisms are associated with freedom from treatment failure for patients with Hodgkin lymphoma.
Christina Heemann; Wolfram Jung; Markus Kreuz; Markus Loeffler; Michael Pfreundschuh; Nils Schoof; Irene Stoller; Lorenz Trümper; Frederike von Bonin; Marita Ziepert; Martin Hafner
Circulating levels of TNF receptor II are prognostic for patients with peripheral T-cell non-Hodgkin lymphoma.
Nils Schoof; Frederike von Bonin; S Zeynalova; M Ziepert; Wolfram Jung; Markus Loeffler; Michael Pfreundschuh; Lorenz Trümper; Martin Hafner
Favorable impact of the interleukin-4 receptor allelic variant I75 on the survival of diffuse large B-cell lymphoma patients demonstrated in a large prospective clinical trial.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Nils Schoof (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Nils Schoof; Lorenz Trümper; Frederike von Bonin; Thomas Zander; Volker Diehl; Andreas Engert; Jeremy Franklin; Robert Fürst; Martin Hafner; Frédéric Peyrade; Daniel Re
Interleukin-10 gene polymorphisms are associated with freedom from treatment failure for patients with Hodgkin lymphoma.
The oncologist 2013;18(1):80-9.
2012: Christina Heemann; Wolfram Jung; Markus Kreuz; Markus Loeffler; Michael Pfreundschuh; Nils Schoof; Irene Stoller; Lorenz Trümper; Frederike von Bonin; Marita Ziepert; Martin Hafner
Circulating levels of TNF receptor II are prognostic for patients with peripheral T-cell non-Hodgkin lymphoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012;18(13):3637-47.
2009: Nils Schoof; Frederike von Bonin; S Zeynalova; M Ziepert; Wolfram Jung; Markus Loeffler; Michael Pfreundschuh; Lorenz Trümper; Martin Hafner
Favorable impact of the interleukin-4 receptor allelic variant I75 on the survival of diffuse large B-cell lymphoma patients demonstrated in a large prospective clinical trial.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2009;20(9):1548-54.
2009: Nils Schoof; Frederike von Bonin; Inke R König; Rotraut Mössner; Ullrich Krüger; Kristian Reich; Carola Berking; Matthias Volkenandt; Andreas Ziegler; L Böckmann; C Kuschal; Kai-Martin Thoms; Martin Hafner; Steffen Emmert
Distal and proximal interleukin (IL)-10 promoter polymorphisms associated with risk of cutaneous melanoma development: a case--control study.
Genes and immunity 2009;10(6):586-90.
2009: Nils Schoof; Frederike von Bonin; Lorenz Trümper; Martin Hafner
HSP90 is essential for Jak-STAT signaling in classical Hodgkin lymphoma cells.
Cell communication and signaling : CCS 2009;7():17.
2008: Martin Hafner; Thanh-Duc Hua; Frederike von Bonin; Nils Schoof; Samira Zeynalova; M Klöss; Daniela Gocht; Bernd Potthoff; Mladen Tzvetkov; Jürgen Brockmöller; Markus Loeffler; Michael Pfreundschuh; Lorenz Trümper
Effect of interleukin-10 gene polymorphisms on clinical outcome of patients with aggressive non-Hodgkin's lymphoma: an exploratory study.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(12):3777-84.
2005: U Holtick; Martina Vockerodt; D Pinkert; Nils Schoof; Benjamin Stürzenhofecker; N Kussebi; Kirsten Lauber; Sebastian Wesselborg; Dennis Löffler; Friedemann Horn; Lorenz Trümper; Martin Hafner
STAT3 is essential for Hodgkin lymphoma cell proliferation and is a target of tyrphostin AG17 which confers sensitization for apoptosis.
Leukemia 2005;19(6):936-44.